Cwm, LLC Acumen Pharmaceuticals, Inc. Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
A detailed history of Cwm, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 744 shares of ABOS stock, worth $1,324. This represents 0.0% of its overall portfolio holdings.
Number of Shares
744
Previous 4,136
82.01%
Holding current value
$1,324
Previous $5,000
80.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABOS
# of Institutions
72Shares Held
36.2MCall Options Held
11.6KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA14.9MShares$26.6 Million0.46% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$6.08 Million2.33% of portfolio
-
Franklin Resources Inc San Mateo, CA2.31MShares$4.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.84 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.65MShares$2.94 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $72.1M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...